News Center

Charlie Javice deserves 12 years prison for defrauding JPMorgan, US says

Charlie Javice deserves 12 years prison for defrauding JPMorgan, US says

By Jonathan Stempel NEW YORK (Reuters) -Charlie Javice, the entrepreneur convicted for defrauding JPMorgan Chase into buying her college financial aid startup Frank for $175 million, should spend 12 years in prison for her crimes, U.S. prosecutors said. In a filing late Monday night in Manhattan federal court, prosecutors said Javice’s fraud reflected "her personal greed and ambition," involving ...

2025-09-17 00:57:16
TSX lower as Bank of Canada and Fed policy decisions loom large

TSX lower as Bank of Canada and Fed policy decisions loom large

Investing.com - Canada’s main stock exchange was lower on Tuesday, as investors awaited key upcoming central bank interest rate decisions later this week. By 12:05 ET, the S&P/TSX 60 index standard futures contract had dipped by 7 points, or 0.4%.The S&P/TSX composite index lost 137 points or 0.47% at 29,293.23.  Amid a torrid recent rally, index posted another all-time peak on ...

2025-09-17 00:54:00
US parents to urge Senate to prevent AI chatbot harms to kids

US parents to urge Senate to prevent AI chatbot harms to kids

By Jody Godoy (Reuters) -Three parents whose children died or were hospitalized after interacting with artificial intelligence chatbots will testify before a U.S. Senate panel on Tuesday, as lawmakers grapple with potential safeguards around the technology. Matthew Raine, who sued OpenAI after his son Adam died by suicide in California after receiving detailed self-harm instructions from ChatGPT, ...

2025-09-17 00:49:55
Eli Lilly to invest $5 billion in new Virginia plant as pharma braces for tariffs

Eli Lilly to invest $5 billion in new Virginia plant as pharma braces for tariffs

By Sneha S K (Reuters) - Eli Lilly said on Tuesday it will invest $5 billion to build a manufacturing facility in Virginia, part of the drugmaker’s broader $27 billion plan to build four facilities across the United States over the next five years. The investment marks Lilly’s latest push to boost domestic drug production and hedge against potential tariffs. Global pharmaceutical companies hav ...

2025-09-17 00:46:47